HUDEX
Price
$28.04
Change
+$0.24 (+0.86%)
Updated
Jul 2 closing price
Net Assets
19.23M
RMFEX
Price
$64.32
Change
+$0.39 (+0.61%)
Updated
Jul 2 closing price
Net Assets
116.64B
Interact to see
Advertisement

HUDEX vs RMFEX

HUDEX vs RMFEX Comparison Chart in %
View a ticker or compare two or three
VS
HUDEX vs. RMFEX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUDEX is a Hold and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 117B vs. HUDEX (19.2M). RMFEX pays higher dividends than HUDEX: RMFEX (1.42) vs HUDEX (1.28). HUDEX was incepted earlier than RMFEX: HUDEX (14 years) vs RMFEX (24 years). HUDEX (1.00) is less costly to investors than RMFEX (0.62). HUDEX is a more actively managed with annual turnover of: 34.00 vs. RMFEX (30.00). RMFEX has a lower initial minimum investment than HUDEX: RMFEX (250) vs HUDEX (1000000). HUDEX annual gain was more profitable for investors over the last year : 14.74 vs. RMFEX (9.90). HUDEX return over 5 years is better than : 61.15 vs. RMFEX (39.16).
HUDEXRMFEXHUDEX / RMFEX
Total Expense Ratio0.760.62123%
Annual Report Gross Expense Ratio1.000.62161%
Fund Existence14 years24 years-
Gain YTD6.8199.40573%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets19.2M117B0%
Annual Yield % from dividends1.281.4290%
Returns for 1 year14.749.90149%
Returns for 3 years53.8337.08145%
Returns for 5 years61.1539.16156%
Returns for 10 years175.59103.50170%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFESX62.101.05
+1.72%
Janus Henderson European Focus S
VMNVX34.590.30
+0.87%
Vanguard Global Minimum Volatility Admr
TRIIX4.840.02
+0.41%
Catalyst/SMH Total Return Income I
NYVCX22.170.01
+0.05%
Davis NY Venture C
MMSIX13.82-0.07
-0.50%
Praxis Small Cap Index I